ImmunityBio
IBRX
IBRX
61 hedge funds and large institutions have $39.8M invested in ImmunityBio in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
61
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$667K | |
| 2 | +$278K | |
| 3 | +$236K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$94.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$73.3K |
Top Sellers
| 1 | -$428K | |
| 2 | -$277K | |
| 3 | -$190K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$178K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$154K |